NY Times

F.D.A. Panel To Meet on J.&J. Boosters

A study that found Johnson & Johnson recipients may benefit more from a booster dose of the Moderna or Pfizer-BioNTech vaccine will also be discussed.

Continue

About the author

Darlene

Leave a Comment